hGH Fragment 176-191 5mg

Description

Targeted Fat Loss and Regenerative Potential

Why Choose HGH Fragment 176-191?

• Effective Fat Burning: Stimulates lipolysis with high selectivity, resulting in significant adipose reduction.
• Blood Sugar Regulation: Helps lower glucose levels, supporting better glycemic control in metabolic studies.
• Cartilage Healing: Promotes cartilage regeneration, ideal for joint and soft-tissue research.
• No Unwanted Growth: Does not stimulate long bone growth or general tissue proliferation, unlike full-length hGH.
• Stable IGF-1 Levels: Maintains IGF-1 without systemic elevation, reducing side-effect risk.
• Insulin Sensitivity: Preserves insulin function, minimizing potential for insulin resistance.

Benefits of HGH Fragment 176-191 in Scientific Research

HGH Fragment 176-191 is widely used in studies related to fat metabolism, insulin signaling, and cartilage repair. Its precision-targeted mechanism and safety profile make it a top-tier peptide for laboratory testing.

How It Works

This fragment isolates the region of the hGH molecule responsible for lipolytic action. It activates beta-3 adrenergic receptors, increasing fat breakdown and thermogenesis. In preclinical models, HGH Fragment 176-191 has demonstrated targeted fat loss effects in obese subjects without impacting lean body mass.

Safety Profile

Multiple studies confirm that HGH Fragment 176-191 does not cause side effects associated with full hGH administration. No adverse changes in glucose levels, IGF-1 concentrations, blood pressure, or edema have been observed. A meta-analysis of six trials shows high tolerability and minimal metabolic disruption.

Ideal Applications

• Obesity and fat metabolism research
• Insulin sensitivity and glycemic control studies
• Joint repair and cartilage regeneration models
• Non-anabolic metabolic therapies

Product Specifications

• Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
• Molecular Formula: C₇₈H₁₂₅N₂₃O₂₃S₂
• Molecular Weight: 1817.12 g/mol
• CAS Number: 66004-57-7

Key Scientific References

• Ng & Bornstein, *Am. J. Physiol.*, 1978 – Discovery of lipolytic activity in GH fragments.
• Heffernan et al., *Endocrinology*, 2001 – Effects on lipid metabolism in obese mice models.
• Ferrer-Lorente et al., *Life Sci.*, 2005 – Study on beta3-adrenergic agonists and lipid stores.
• Ng et al., *Horm. Res.*, 2000 – Metabolic studies of AOD9604.
• Stier et al., *J. Endocrinol. Metab.*, 2013 – Human trials on safety and tolerability.
• Heffernan et al., *Int. J. Obes.*, 2001 – Comparison of full hGH vs. fragment in fat oxidation.
• Kwon & Park, *Ann. Clin. Lab. Sci.*, 2015 – Cartilage recovery with AOD9604 injections.

Usage Disclaimer

For Research Use Only: This compound is strictly intended for in vitro laboratory research. Not for human or veterinary use. Not a drug, food, or cosmetic. This product has not been evaluated or approved by the FDA. It must be handled by qualified, licensed professionals in certified research environments.

Conclusion

HGH Fragment 176-191 is a next-generation peptide designed for focused fat metabolism and regenerative applications without the systemic side effects of full hGH. For researchers seeking a reliable tool in the study of obesity, metabolic disorders, or tissue repair, this fragment offers a precise, safe, and research-backed solution.